Results 171 to 180 of about 5,363,495 (332)

Synthesis of Polyfluoroalkyl Substituted Cyclobutenes from 3-Aza-1,5-enynes via an Aza-ClaisenRearrangementCyclization Cascade

, 2013
Synthesis of Polyfluoroalkyl Substituted Cyclobutenes from 3-Aza-1,5-enynes via an Aza-ClaisenRearrangementCyclization ...
王春翔, 王浩龙, 吴凡, 王东平, 万伯顺, 李新成, 信晓义   +6 more
core  

Novel nitro‐quinoline photoinitiators for composites: exploring the effects of hydroxyl and methacrylate substituents on the photopolymerization of dimethacrylate matrices

Polymer International, EarlyView.
New quinoline derivatives proved to be efficient photoinitiators for dental resin monomers under two different light‐curing units, yielding favorable conversion, color and fluorescence results in the presence of different co‐initiators, including an eco‐friendly alternative.
Vitor Fernandes Moreno, Luiz Carlos da Silva‐Filho, Adilson Yoshio Furuse   +2 more
wiley   +1 more source

Strategies for Enantioselective, Cascade, Valorizing, and Expanded Heterocyclic Piancatelli Rearrangements. [PDF]

ACS Org Inorg Au
K ATG, Kizirian M, Picazo E.
europepmc   +1 more source

Photochemical Synthesis of Aza-aromatic Compounds.

, 2017
Herein we report synthesis of series of novel both aza- and diaza-helicenes, and phenacenes, which were prepared mainly by photocyclization of corresponding imine precursors. Reaction conditions of photocyclization (i.e. solvent, photocatalyst, type of irradiation, use of water scavenger) were optimized and enhanced.
openaire   +1 more source

Epigenetic Regulation of Liver Fibrosis: Mechanisms and Therapeutic Implications

Portal Hypertension &Cirrhosis, EarlyView.
This review synthesizes the epigenetic mechanisms—DNA methylation, histone modifications, and non‐coding RNAs—that drive hepatic stellate cell activation and the progression of liver fibrosis. It further evaluates emerging therapeutic strategies targeting these epigenetic regulators, including DNA methyltransferase and histone deacetylase inhibitors ...
Maryam Jadid Tavaf, Mahboobeh Ebrahimi Varkiani, Saeid Abroun, Pedram Asadi‐Sarabi, Shukoofeh Torabi, Elham Rismani, Mohammad Majd Hammour, Andreas K. Nüssler, Massoud Vosough   +8 more
wiley   +1 more source

Novel 3‑Aza-Bicyclo[3.3.0]octane Compounds as ERK5 Inhibitors for Treating Cancer. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

2‐Amino‐3H‐phenoxazin‐3‐one is a lead inhibitor of Cuscuta campestris early development: structure–activity relationships of o‐aminophenol‐derived allelochemicals

Pest Management Science, EarlyView.
Phenoxazinones caused differential types of phytotoxic effects in C. campestris early development. APO is a coherent lead inhibiting C. campestris germination and early seedling growth. Abstract BACKGROUND 2‐Amino‐3H‐phenoxazin‐3‐one (synonym: questiomycin A; abbreviated as APO or Phx‐3) is a naturally occurring phenoxazinone‐type allelochemical with ...
Cristina Díaz‐Franco, Mónica Fernández‐Aparicio, José MG Molinillo, Rosa M Varela, Francisco A Macías, Jesús G Zorrilla   +5 more
wiley   +1 more source

Novel tetronamides derived from mucobromic acid: synthesis, structural elucidation, DFT calculations and phytotoxic activity

Pest Management Science, EarlyView.
The acyclic mucobromic acid, activated by (1S)‐(+)‐10‐camphorsulfonic acid, afforded the chiral compound 1b, precursor for aza‐Michael addition/elimination on the butenolide yielding tetronamides 2b‐7b. Their relative SRSR configuration was confirmed by the spectrometric methods, DFT calculation and statistical methods.
Kamylla CF Faria, Vitor C Baia, Elson S Alvarenga   +2 more
wiley   +1 more source

Organocatalytic Asymmetric Formal Aza-[3 + 2] Cycloaddition via Domino Michael/Acetalization: Stereoselective Access to 3,4-<i>cis</i>-Disubstituted Pyrrolidines and Pot-Economical Total Syntheses of (-)-Kainic Acid and (-)-Domoic Acid. [PDF]

JACS Au
Hatano Y, Odaira H, Tachibana T, Hayashi Y.   +3 more
europepmc   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source